HIV and SIV Envelope Glycoproteins Interact with Glycolipids and Lipids

The present study demonstrates that, in addition to interacting with galactosylceramide (GalCer), HIV-1, HIV-2, and SIV envelope glycoproteins are able to interact with glucosylceramide (GlcCer), lactosylceramide (LacCer), and ceramide. These interactions were characterized by using three complement...

Full description

Bibliographic Details
Main Authors: Rémi Planes, Elmostafa Bahraoui
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/14/11730
_version_ 1797588946550521856
author Rémi Planes
Elmostafa Bahraoui
author_facet Rémi Planes
Elmostafa Bahraoui
author_sort Rémi Planes
collection DOAJ
description The present study demonstrates that, in addition to interacting with galactosylceramide (GalCer), HIV-1, HIV-2, and SIV envelope glycoproteins are able to interact with glucosylceramide (GlcCer), lactosylceramide (LacCer), and ceramide. These interactions were characterized by using three complementary approaches based on molecular binding and physicochemical assays. The binding assays showed that iodinated radiolabeled HIV-1 and HIV-2 glycoproteins (<sup>125</sup>I-gp) interact physically with GalCer, GlcCer, LacCer, and ceramide previously separated by thin layer chromatography (TLC) or directly coated on a flexible 96-well plate. These interactions are specific as demonstrated, on the one hand, by the dose-dependent inhibition in the presence of various dilutions of immune, but not non-immune, sera, and, on the other hand, by the absence of interaction of these glycolipids/lipids with <sup>125</sup>I-IgG used as an unrelated control protein. These interactions were further confirmed in a physicochemical assay, based on the capacity of these glycolipids for insertion in a pre-established monomolecular film, as a model of the cell membrane, with each glycolipid/lipid. The addition of HIV envelope glycoproteins, but not ovomucoid protein used as a negative control, resulted in a rapid increase in surface pressure of the glycolipid/lipid films, thus indirectly confirming their interactions with GalCer, GlcCer, LacCer, and ceramide. In summary, we show that HIV and SIV envelope glycoproteins bind to GalCer, GlcCer, LacCer, and ceramide in a dose-dependent, saturable, and specific manner. These interactions may function as receptors of attachment in order to facilitate infection of CD4 low or negative cells or promote interactions with other receptors leading to the activation of signaling pathways or pathogenesis.
first_indexed 2024-03-11T00:59:16Z
format Article
id doaj.art-0129d76dff4a4c058eb5887aaae8216c
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T00:59:16Z
publishDate 2023-07-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-0129d76dff4a4c058eb5887aaae8216c2023-11-18T19:44:04ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-07-0124141173010.3390/ijms241411730HIV and SIV Envelope Glycoproteins Interact with Glycolipids and LipidsRémi Planes0Elmostafa Bahraoui1INFINITY, INSERM, CNRS, CHU Purpan Toulouse, 31024 Toulouse, FranceINFINITY, INSERM, CNRS, CHU Purpan Toulouse, 31024 Toulouse, FranceThe present study demonstrates that, in addition to interacting with galactosylceramide (GalCer), HIV-1, HIV-2, and SIV envelope glycoproteins are able to interact with glucosylceramide (GlcCer), lactosylceramide (LacCer), and ceramide. These interactions were characterized by using three complementary approaches based on molecular binding and physicochemical assays. The binding assays showed that iodinated radiolabeled HIV-1 and HIV-2 glycoproteins (<sup>125</sup>I-gp) interact physically with GalCer, GlcCer, LacCer, and ceramide previously separated by thin layer chromatography (TLC) or directly coated on a flexible 96-well plate. These interactions are specific as demonstrated, on the one hand, by the dose-dependent inhibition in the presence of various dilutions of immune, but not non-immune, sera, and, on the other hand, by the absence of interaction of these glycolipids/lipids with <sup>125</sup>I-IgG used as an unrelated control protein. These interactions were further confirmed in a physicochemical assay, based on the capacity of these glycolipids for insertion in a pre-established monomolecular film, as a model of the cell membrane, with each glycolipid/lipid. The addition of HIV envelope glycoproteins, but not ovomucoid protein used as a negative control, resulted in a rapid increase in surface pressure of the glycolipid/lipid films, thus indirectly confirming their interactions with GalCer, GlcCer, LacCer, and ceramide. In summary, we show that HIV and SIV envelope glycoproteins bind to GalCer, GlcCer, LacCer, and ceramide in a dose-dependent, saturable, and specific manner. These interactions may function as receptors of attachment in order to facilitate infection of CD4 low or negative cells or promote interactions with other receptors leading to the activation of signaling pathways or pathogenesis.https://www.mdpi.com/1422-0067/24/14/11730HIV receptorslipidsglycolipids
spellingShingle Rémi Planes
Elmostafa Bahraoui
HIV and SIV Envelope Glycoproteins Interact with Glycolipids and Lipids
International Journal of Molecular Sciences
HIV receptors
lipids
glycolipids
title HIV and SIV Envelope Glycoproteins Interact with Glycolipids and Lipids
title_full HIV and SIV Envelope Glycoproteins Interact with Glycolipids and Lipids
title_fullStr HIV and SIV Envelope Glycoproteins Interact with Glycolipids and Lipids
title_full_unstemmed HIV and SIV Envelope Glycoproteins Interact with Glycolipids and Lipids
title_short HIV and SIV Envelope Glycoproteins Interact with Glycolipids and Lipids
title_sort hiv and siv envelope glycoproteins interact with glycolipids and lipids
topic HIV receptors
lipids
glycolipids
url https://www.mdpi.com/1422-0067/24/14/11730
work_keys_str_mv AT remiplanes hivandsivenvelopeglycoproteinsinteractwithglycolipidsandlipids
AT elmostafabahraoui hivandsivenvelopeglycoproteinsinteractwithglycolipidsandlipids